TheraRadar
← Back
Data updated: Mar 29, 2026

GLENMARK PHARMS LTD

CardiovascularNeurologyDermatology
Generics

GLENMARK PHARMS LTD is a generic drug manufacturer focused on Cardiovascular, Neurology, Dermatology.

2005
Since
144
Drugs
-
Trials
1336
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 39%
13 drugs
Neurology 18%
6 drugs
Dermatology 18%
6 drugs
Oncology 15%
5 drugs
Immunology 9%
3 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...